ID: ALA2303855

Max Phase: Preclinical

Molecular Formula: C17H30N2O11

Molecular Weight: 438.43

Molecule Type: Small molecule

Representations

Canonical SMILES:  CO[C@@H]1O[C@@H](CNC=O)[C@@H](O[C@@H]2O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]2OC)[C@H](O)[C@@H]1NC(C)=O

Standard InChI:  InChI=1S/C17H30N2O11/c1-7(22)19-10-12(24)14(8(4-18-6-21)28-16(10)27-3)30-17-15(26-2)13(25)11(23)9(5-20)29-17/h6,8-17,20,23-25H,4-5H2,1-3H3,(H,18,21)(H,19,22)/t8-,9-,10-,11-,12+,13-,14+,15-,16+,17-/m0/s1

Standard InChI Key:  HVYCKNTUAWNMCU-VKDBSKBYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 438.43

Molecular Weight (Monoisotopic): 438.1850

AlogP: -4.19

#Rotatable Bonds: 9

Polar Surface Area: 185.27

Molecular Species: NEUTRAL

HBA: 11

HBD: 6

#RO5 Violations: 2

HBA (Lipinski): 13

HBD (Lipinski): 6

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 12.14

CX Basic pKa:

CX LogP: -4.04

CX LogD: -4.04

Aromatic Rings: 0

Heavy Atoms: 30

QED Weighted: 0.19

Np Likeness Score: 1.50

References

1. Galan MC, Dodson CS, Venot AP, Boons GJ..  (2004)  Glycosyltransferase activity can be selectively modulated by chemical modifications of acceptor substrates.,  14  (9): [PMID:15081009] [10.1016/j.bmcl.2004.02.024]

Source

Source(1):

• Scientific Literature